Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial

JAMA

Volumn 280, Issue 2, 1998, Pages 159-165

  Meduri, G Umberto ^a,b   Headley, A Stacey ^a   Golden, Emmel ^a   Carson, Stephanie J ^a   Umberger, Reba A ^a   Kelso, Tiffany ^b   Tolley, Elizabeth A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032496894     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.2.159     Document Type: Article

References (44)

1. Meduri GU. The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J. 1996;9:2650-2670.
2. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med. 1995;332:27-37.
3. Krafft P, Fridrich P, Pernerstorfer T, et al. The acute respiratory distress syndrome: definitions, severity and clinical outcome: an analysis of 101 clinical investigations. Intensive Care Med. 1996;22: 519-529.
4. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987; 317:1565-1570.
5. 2 ratio and its response to conventional therapy. Chest. 1989;96: 849-851.
6. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 1997;111:1306-1321.
7. Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995;23:1294-1303.
8. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and metaanalysis of the literature. Crit Care Med. 1995;23: 1430-1439.
9. Hooper RG, Kearl RA. Established ARDS treated with a sustained course of adrenocorticol steroids. Chest. 1990;97:138-143.
10. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids. Chest. 1991;100:943-952.
11. Meduri GU, Chinn AJ, Leeper KV, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest. 1994;105:1516-1527.
12. Meduri GU, Headley S, Tolley E, Shelby M, Stentz F, Postlethwaite A. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest. 1995;108:1315-1325.
13. Hooper RG, Kearl RA. Established adult respiratory distress syndrome successfully treated with corticosteroids. South Med J. 1996;89:359-364.
14. Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome: diagnosis and treatment. Arch Surg. 1985;120:530-535.
15. Biffl WL, Moore FA, Moore EE, Haenel JB, McIntyre RC, Burch JM. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg. 1995;170:591-596.
16. Whitehead J. The Design and Analysis of Sequential Clinical Trials. New York, NY: John Wiley & Sons Inc; 1983.
17. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
18. Slutsky AS. Mechanical ventilation. Chest. 1993; 104:1833-1859.
19. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest. 1992;102(suppl):557S-564S.
20. Reddy R, Meduri GU, Stanley T, Umberger R, Headley S. Bilateral BAL to diagnose ventilator-associated pneumonia (VAP) in ARDS [abstract]. Am J Respir Crit Care Med. 1997;155:A393.
21. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 1994;106:221-235.
22. Tornatore KM, Logue G, Venuto RC, et al. Pharmacokinetics of methylprednisolone in elderly and young healthy males. J Am Geriatr Soc. 1994;42: 1118-1122.
23. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138: 720-723.
24. Bernard GR, Doig G, Hudson LD, et al. Quantification of organ failure for clinical trials [abstract]. Am J Respir Crit Care Med. 1995;151:A323.
25. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992; 101:1644-1655.
26. Sokal RR, Rohlf FJ. Comparisons among means: planned comparisons. In: Biometry. 2nd ed. New York, NY: WH Freeman & Co; 1981:232-242.
27. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
28. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 are consistent and efficient predictors of outcome over time. Chest. 1995;107:1062-1073.
29. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest. 1995;108:1303-1314.
30. Meduri GU, El Torky M, Winer-Muram HT. The fibroproliferative phase of late adult respiratory distress syndrome. Semin Respir Infect. 1995;10: 154-175.
31. Shen AS, Haslett DC, Feldsien C, Henson PM, Cherniack RM. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis. 1988;137:564-571.
32. Jones RL, King EG. The effects of methylprednisolone on oxygenation in experimental hypoxemic respiratory failure. J Trauma. 1975;15:297-303.
33. Hesterberg TW, Last JA. Ozone-induced acute pulmonary fibrosis in rats - prevention of increased rates of collagen synthesis by methylprednisolone. Am Rev Respir Dis. 1981;123:47-52.
34. Hakkinen PJ, Schmoyer RL, Witschi HP. Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen: effects of prednisolone and indomethacin. Am Rev Respir Dis. 1983; 128:648-651.
35. Briegel J, Kellermann W, Forst H, et al. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. Clin Invest. 1994;72:782-787.
36. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiological doses of hydrocortisone. Crit Care Med. 1998;26: 645-650.
37. Kehrer JP, Klein-Szanto AJP, Sorensen EMB, Pearlman R, Rosner MH. Enhanced acute lung damage following corticosteroid treatment. Am Rev Respir Dis. 1984;130:256-261.
38. Barber AE, Coyle SM, Marano MA, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol. 1993; 150:1999-2006.
39. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, and the Methylprednisolone Severe Sepsis Study Group. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92:1032-1036.
40. Bamberger CM, Shulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17:245-261.
41. Marx J. How glucocorticoids suppress immunity. Science. 1995;270:232-233.
42. Barnes PJ, Adcock IM. Glucocorticoid receptors. In: Crystal RG, West JB, Weibel ER, et al, eds. The Lung: Scientific Foundations. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:37-56.
43. Kew KH, Ludwig EA, Milad MA, et al. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 1993;54:402-414.
44. Meduri GU, Headley EA, Tolley A, et al. Plasma and BAL procollagen type I and III levels during ARDS and in response to prolonged methylprednisolone treatment [abstract]. Am J Respir Crit Care Med. 1998;157:A460.